Home Depot price target lowered to $323 from $327 at Piper Sandler 06:07 HD Piper Sandler analyst Peter Keith lowered the firm's price target on Home Depot to $323 from $327 and keeps a Neutral rating on the shares. The analyst views the company's Q3 results as "solid." While macro metrics on the housing market have been unfavorable, Home Depot's sales trends are holding steady on a three-year basis, as Pro spending remains strong and numerous project-based categories posted double-digit comp growth, Keith tells investors in a research note.
New Fortress Energy price target raised to $53 from $48 at Barclays 05:56 NFE Barclays analyst Marc Solecitto raised the firm's price target on New Fortress Energy to $53 from $48 and keeps an Equal Weight rating on the shares. The analyst continues to view the run-rate valuation as fair on a risk-adjusted basis following the company's Q3 results.
Harmony Biosciences director sells $9.12M in common stock 19:55 HRMY In a regulatory filing, Harmony Biosciences disclosed that its director Jack Nielsen sold 158.4K shares of common stock on November 11th in a total transaction size of $9.12M.